Will Ashworth

Will Ashworth

InvestorPlace Contributor

Expertise: Public and private companies, Portfolio construction

About Will:
Will Ashworth has written about investments full-time since 2008. He loves investing and is passionate about helping others put their money to work. He particularly enjoys creating model portfolios that stand the test of time.

Publications where he’s appeared include InvestorPlace, The Motley Fool Canada, Investopedia, Kiplinger, and several others in both the U.S. and Canada. He lives in Halifax, Nova Scotia.

You can follow Will on LinkedIn. 

Recent Articles

GrowGeneration Stock: Where There’s Smoke, There’s Usually Fire

By Will Ashworth, InvestorPlace Contributor

The smoke circling GrowGeneration stock suggests investors might want to take their time buying into this growth story.

Aggressive Investors Have No Excuse for Not Owning Moderna

By Will Ashworth, InvestorPlace Contributor

Canada just ordered 20 million doses of Moderna’s Covid-19 vaccine. That’s excellent news for anyone who owns MRNA stock, Canadians included.

10 Stocks For Beginners To Buy Today For Profits Tomorrow

By Will Ashworth, InvestorPlace Contributor

The novel coronavirus and resulting quarantine led a lot of new investors to join in the markets. Here are 10 stocks for beginners to buy.

Jeff Bezos and His Ex Have $84 Billion Reasons to Be Thankful for Amazon in 2020

By Will Ashworth, InvestorPlace Contributor

Jeff Bezos and his ex-wife Mackenzie Scott are $84 billion richer in 2020. All because of AMZN stock. Can the good times continue?

Luckin Stock Has Lots of Troubles, Sean Shao Looks to Be the Solution

By Will Ashworth, InvestorPlace Contributor

Luckin Coffee reinstated Sean Shao as one of its four independent directors. Who is Sean Shao and what does this mean for Luckin stock?

Nvidia’s $40 Billion Deal Brings a Stock Split into the Picture

By Will Ashworth, InvestorPlace Contributor

Nvidia’s paying $40 billion for U.K.-based ARM Holdings. That’s pushed NVDA stock past $500. Is it time for the company to split its stock?

Germany Makes a $299 Million Bet on CureVac

By Will Ashworth, InvestorPlace Contributor

CureVac recently was awarded $299 million to support the development of its Covid-19 vaccine. What does this mean for CureVac stock?  

Landcadia Holdings II Will End Up Just Like Tilman Fertitta’s First SPAC

By Will Ashworth, InvestorPlace Contributor

Tilman Fertitta’s first special purpose acquisition company flamed out. Why should Landcadia Holdings II and LCA stock be any different?  

DiamondPeak Holdings May Be Getting a Bit Expensive

By Will Ashworth, InvestorPlace Contributor

InvestorPlace published a list of 23 electric car stocks to watch. DiamondPeak stock was on the list, but its shares may be a tad expensive.

7 Fitness Stocks to Buy for the Pandemic and Beyond

By Will Ashworth, InvestorPlace Contributor

Covid-19 has created a lot of new fitness buffs. Here are seven fitness stocks to benefit from the pandemic without leaving your couch.   

Load More